Осимертиниб - analogs
Components: Osimertinib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Осимертиниб | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Гинкос -гинкго билоба с синюхой голубой. Серия «Сокровище Шамбалы» ✘ (incl) Lokap ✘ (incl) Гликор ✘ (incl) Multimax Beauty Lux New ✘ (incl) Kindervit D3 ✘ (incl) Бацидерм ✘ (incl) FitLine ProShape (Amino) ✘ (incl) Флаванон ✘ (incl) Рыбий жир пищевой - Мирролла серии «Мирролла» ✘ (incl) Flekrizan ✘ (incl) Figur Balance Brause ✘ (incl) Алексиния ✘ (incl) Фиточай Байкальский «Боярки плоды» ✘ (incl) Альфамеколь ✘ (incl) Гематоген с витаминами ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Tagrisso neutral | 5550€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% — Zykadia neutral [Ceritinib]
- 50% — Gefitinib neutral [Gefitinib]
- 50% 1114€ Iressa neutral [Gefitinib]
- 45% 637.5-902.1€ Giotrif neutral [Afatinib]
- 42% 2535.2€ Alecensa neutral [Alectinib]
- 42% — Tarlenib neutral [Erlotinib]
- 40% 838€ Tarceva neutral [Erlotinib]
- 38% — Эрлотиниб-тл neutral [Erlotinib]
- 37% — Erlotinib - native neutral [Erlotinib]
- 37% 2103.9€ Mekinist neutral [Trametinib]
- 37% — Гефитиниб-Рус neutral [Gefitinib]
- 37% — Гефитиниб-промомед neutral [Gefitinib]
- 35% 2701.7-2704.5€ Xalkori neutral [Crizotinib]
- 35% — Erlotinib neutral [Erlotinib]
- 31% — Пемджем neutral [Pemetrexed]
- 31% 407.7€ Pemetrexed neutral [Pemetrexed]
- 31% — Pemetrexed disodium neutral [Pemetrexed]
- 31% — Verotrexed neutral [Pemetrexed]
- 31% — Антифолат neutral [Pemetrexed]
- 31% — Pemetrexed-nativ neutral [Pemetrexed]
- 31% — Пеметрексед Канон neutral [Pemetrexed]
- 31% — Пеметрекседа динатрия гептагидрат neutral [Pemetrexed]
- 31% 447.2-480€ Alimta neutral [Pemetrexed]
- 31% — Фолитрекс neutral [Pemetrexed]
- 31% 76.2-377.7€ Пемелан neutral [Pemetrexed]
- 31% — Pemetrexed J neutral [Pemetrexed]
- 31% — ИСПОЛАТ neutral [Pemetrexed]
- 31% — Pemetrexed-TL neutral [Pemetrexed]
- 31% — Пеметрексед-промомед neutral [Pemetrexed]
- 31% — Пеметрекседа динатрия гемипентагидрат neutral [Pemetrexed]
- 31% — Пеметрексед-Келун-Казфарм neutral [Pemetrexed]
- 31% — Пеметрексед-ДЕКО neutral [Pemetrexed]
- 31% — Пеметрексед-Рус neutral [Pemetrexed]
- 29% 1199.1€ Risarg neutral [Ribociklib]
- 29% 993.9-2945.6€ Caprelsa neutral [Vandetanib]
- 28% 1274.7€ Tyverb neutral [Lapatinib]
- 28% — Лорвиква neutral [Lorlatinib]
- 27% 862.9€ Vargatef neutral [Nintedanib]
- 25% 798-825€ Ibrance neutral [Palbociclib]
- 25% 807.2-809.8€ Итулси neutral [Palbociclib]
- 25% — Vinorelbine tartrate neutral [Vinorelbine]
- 25% — Vincarelbine neutral [Vinorelbine]
- 25% — Vinorelbine medac neutral [Vinorelbine]
- 25% 9.4-25.8€ Vinelbine neutral [Vinorelbine]
- 25% — Vinorelbine bitartrate neutral [Vinorelbine]
- 24% 2683.5€ Tafinlar neutral [Dabrafenib]
- 24% — Verzenio neutral [Abemaciclib]
- 24% 1723.4-1727€ Cotellic neutral [Cobimetinib]
- 24% — Imfinzi neutral [Durvalumab]
- 24% — Sorafenib neutral [Sorafenib]
Learn more about the selection of analogues
- The drug has «Осимертиниб» 2 full analogs, the cheapest - Tagrisso (5550€); 51 analog by action, the most similar - Iressa (1114€).
- Medical online service has selected the best substitutes for Осимертиниб based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Осимертиниб analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.